Elevated level of nitric oxide mediates the anti-depressant effect of rubidium chloride in mice

European Journal of Pharmacology

Volumn 762, Issue , 2015, Pages 411-418

  Kordjazy, Nastaran ^a,b,c   Haj Mirzaian, Arya ^b,c   Amiri, Shayan ^b,c   Ostadhadi, Sattar ^b,c   Kordjazy, Mehdi ^d   Sharifzadeh, Mohammad ^a   Dehpour, Ahmad Reza ^b,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Forced swimming test; Mice; Nitric oxide; Rubidium chloride; Tail suspension test

Indexed keywords

NITRIC OXIDE; RUBIDIUM CHLORIDE; ANTIDEPRESSANT AGENT; CHLORIDE; ENZYME INHIBITOR; NITRIC OXIDE SYNTHASE; NITRITE; RUBIDIUM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIOR CHANGE; BLOOD LEVEL; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; FORCED SWIM TEST; HIPPOCAMPUS; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; TAIL SUSPENSION TEST; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DRUG EFFECTS; METABOLISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CHLORIDES; ENZYME INHIBITORS; HIPPOCAMPUS; MALE; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; RUBIDIUM;

EID: 84933556007     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.06.030     Document Type: Article

References (55)

1. M. Adachi, M. Abe, T. Sasaki, H. Kato, J. Kasahara, and T. Araki Role of inducible or neuronal nitric oxide synthase in neurogenesis of the dentate gyrus in aged mice Metab. Brain Dis. 25 2010 419 424
2. Y. Amitai Physiologic role for "inducible" nitric oxide synthase: a new form of astrocytic-neuronal interface Glia 58 2010 1775 1781
3. B. Arroll, S. Macgillivray, S. Ogston, I. Reid, F. Sullivan, B. Williams, and I. Crombie Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis Ann. Fam. Med. 3 2005 449 456
4. P. Baker, A. Hodgkin, and T. Shaw The effects of changes in internal ionic concentrations on the electrical properties of perfused giant axons J. Physiol. 164 1962 355
5. A. Brundusino, and S. Cairoli The pharmacological action of rubidium chloride in depression Minerva Psichiatr. 37 1996 45
6. S. Campbell, and G. MacQueen The role of the hippocampus in the pathophysiology of major depression J. Psychiatry Neurosci. 29 2004 417
7. B.J. Carroll, and P.T. Sharp Rubidium and lithium: opposite effects on amine-mediated excitement Science 172 1971 1355 1357
8. M. Casacchia, A. Rossi, V. Marola, and G. Meco The use of rubidium chloride in depressive disorders: clinical aspects, current trends in lithium and rubidium therapy 1984 Springer 255 259
9. V. Castagné, P. Moser, S. Roux, and R.D. Porsolt Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice Curr. Protoc. Neurosci. 55 2011 11 18.10
10. W.E. Chrapko, P. Jurasz, M.W. Radomski, N. Lara, S.L. Archer, and J.-M. Le Mellédo Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder Biol. Psychiatry 56 2004 129 134
11. J.F. Cryan, C. Mombereau, and A. Vassout The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice Neurosci. Biobehav. Rev. 29 2005 571 625
12. Gd.L. da Silva, A.S. Matteussi, A.R.S. dos Santos, J.B. Calixto, and A.L.S. Rodrigues Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice Neuroreport 11 2000 3699 3702
13. D.J.P. David, C.E. Renard, P. Jolliet, M. Hascoët, and M. Bourin Antidepressant-like effects in various mice strains in the forced swimming test Psychopharmacology 166 2003 373 382
14. M., Ph.D. Dawson, M. Ted, P.D. Dawson, and L. Valina Nitric oxide synthase: role as a transmitter/mediator in the brain and endocrine system Annu. Rev. Med. 47 1996 219 227
15. A. Dhir, and S. Kulkarni Nitric oxide and major depression Nitric Oxide 24 2011 125 131
16. J. Ding, Q.Y. Li, X. Wang, C.H. Sun, C.Z. Lu, and B.G. Xiao Fasudil protects hippocampal neurons against hypoxia-reoxygenation injury by suppressing microglial inflammatory responses in mice J. Neurochem. 114 2010 1619 1629
17. R.S. Duman, S. Nakagawa, and J. Malberg Regulation of adult neurogenesis by antidepressant treatment Neuropsychopharmacology 25 2001 836 844
18. J.V. Esplugues NO as a signalling molecule in the nervous system Br. J. Pharmacol. 135 2002 1079 1095
19. R.R. Fieve Rubidium: biochemical, behavioral and metabolic studies in humans Am. J. Psychiatry 130 1973 55 61
20. C. Gambarana, O. Ghiglieri, F. Masi, S. Scheggi, A. Tagliamonte, and M.G. De Montis The effects of long-term administration of rubidium or lithium on reactivity to stress and on dopamine output in the nucleus accumbens in rats Brain Res. 826 1999 200 209
21. M. Ghasemi, H. Sadeghipour, A. Mosleh, H.R. Sadeghipour, A.R. Mani, and A.R. Dehpour Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test Eur. Neuropsychopharmacol. 18 2008 323 332
22. B. Glendening, W. Schrenk, and D. Parrish Effects of rubidium in purified diets fed rats J. Nutr. 60 1956 563 579
23. D.L. Granger, R.R. Taintor, K.S. Boockvar, and J.B. Hibbs Jr Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction Methods Enzymol. 268 1996 142 151
24. A. Haj-Mirzaian, N. Hamzeh, M. Javadi-Paydar, M.R.A. Estakhri, and A.R. Dehpour Resistance to depression through interference of opioid and nitrergic systems in bile-duct ligated mice Eur. J. Pharmacol. 708 2013 38 43
25. A. Haj-Mirzaian, S. Ostadhadi, N. Kordjazy, A.R. Dehpour, and S. Ejtemaei Mehr Opioid/NMDA receptors blockade reverses the depressant-like behavior of foot shock stress in the mouse forced swimming test Eur. J. Pharmacol. 735 2014 26 31
26. A. Harkin, T.J. Connor, M.P. Burns, and J.P. Kelly Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test Eur. Neuropsychopharmacol. 14 2004 274 281
27. A.J. Harkin, K.H. Bruce, B. Craft, and I.A. Paul Nitric oxide synthase inhibitors have antidepressant-like properties in mice: 1. Acute treatments are active in the forced swim test Eur. J. Pharmacol. 372 1999 207 213
28. B.H. Harvey Affective disorders and nitric oxide: a role in pathways to relapse and refractoriness? Human Psychopharmacol.: Clin. Exp. 11 1996 309 319
29. H. Herken, A. Gurel, S. Selek, F. Armutcu, M.E. Ozen, M. Bulut, O. Kap, M. Yumru, H.A. Savas, and O. Akyol Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment Arch. Med. Res. 38 2007 247 252
30. S.Y. Inan, I. Yalcin, and F. Aksu Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation Pharmacol. Biochem. Behav. 77 2004 457 464
31. D. Jefferys, and J. Funder Nitric oxide modulates retention of immobility in the forced swimming test in rats Eur. J. Pharmacol. 295 1996 131 135
32. S.R.L. Joca, and F.S. Guimarães Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects Psychopharmacology 185 2006 298 305
33. J. Karatinos, R.B. Rosse, and S.I. Deutsch The nitric oxide pathway: potential implications for treatment of neuropsychiatric disorders Clin. Neuropharmacol. 18 1995 482 499
34. Z. Ma, W. Ji, R. Qu, M. Wang, W. Yang, Z. Zhan, Q. Fu, and S. Ma Metabonomic study on the antidepressant-like effects of banxia houpu decoction and its action mechanism Evid.-Based Complement. Altern. Med. 2013 2013
35. M. Mantovani, R. Pértile, J.B. Calixto, A.R. Santos, and A.L.S. Rodrigues Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-d-aspartate receptors and the l-arginine-nitric oxide pathway Neurosci. Lett. 343 2003 1 4
36. H. Meltzer, R.T.S. Platman, and R. Fieve Rubidium: a potential modifier of affect and behaviour Nature 223 1969 321 322
37. M. Moretti, A. Colla, G. de Oliveira Balen, D.B. dos Santos, J. Budni, A.E. de Freitas, M. Farina, and A.L. Severo Rodrigues Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress J. Psychiatric Res. 46 2012 331 340
38. C. Paschalis, F. Jenner, and C. Lee Effects of rubidium chloride on the course of manic-depressive illness J. R. Soc. Med. 71 1978 343
39. S.B. Pinnock, R. Balendra, M. Chan, L.T. Hunt, T. Turner-Stokes, and J. Herbert Interactions between nitric oxide and corticosterone in the regulation of progenitor cell proliferation in the dentate gyrus of the adult rat Neuropsychopharmacology 32 2006 493 504
40. G. Placidi, A. Lenzi, F. Lazzerini, L. Dell'Osso, G.B. Cassano, and H.S. Akiskal Exploration of the clinical profile of rubidium chloride in depression: a systematic open trial J. Clin. Psychopharmacol. 8 1988 184 188
41. R. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch. Int. Pharmacodyn. Thér. 229 1977 327
42. R.D. Porsolt, M. Le Pichon, and M. Jalfre Depression: a new animal model sensitive to antidepressant treatments Nature 266 1977 730 732
43. M.S. Sadaghiani, M. Javadi-Paydar, M.H. Gharedaghi, Y.Y. Fard, and A.R. Dehpour Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway Behav. Brain Res. 224 2011 336 343
44. J.J. Schildkraut, S.M. Schanberg, G.R. Breese, and I.J. Kopin Norepinephrine metabolism and drugs used in the affective disorders: A possible mechanism of action Am. J. Psychiatry 124 1967 600 608
45. S. Selek, H.A. Savas, H.S. Gergerlioglu, F. Bulbul, E. Uz, and M. Yumru The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode J. Affect. Disord. 107 2008 89 94
46. M.L. Selley Increased ( E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression J. Affect. Disord. 80 2004 249 256
47. Y.I. Sheline, M.H. Gado, and H.C. Kraemer Untreated depression and hippocampal volume loss Am. J. Psychiatry 160 2003 1516 1518
48. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl.) 85 1985 367 370
49. E. Suzuki, G. Yagi, T. Nakaki, S. Kanba, and M. Asai Elevated plasma nitrate levels in depressive states J. Affect. Disord. 63 2001 221 224
50. R. Torta, G. Ala, R. Borio, A. Cicolin, S. Costamagna, L. Fiori, and L. Ravizza Rubidium chloride in the treatment of major depression Minerva Psichiatr. 34 1993 101
51. R. Villanueva Neurobiology of major depressive disorder Neural Plast. 2013 2013
52. G. Wegener, and V. Volke Nitric oxide synthase inhibitors as antidepressants Pharmaceuticals 3 2010 273 299
53. R. Williams, A. Maturen, and H. Sky-Peck Pharmacologic role of rubidium in psychiatric research Compr. Ther. 13 1987 46
54. F. Yildiz, B.F. Erden, G. Ulak, T. Utkan, and N. Gacar Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats Psychopharmacology 149 2000 41 44
55. L.T. Young Neuroprotective effects of antidepressant and mood stabilizing drugs J. Psychiatry Neurosci. 27 2002 8